In the last 25 years, intravenous immunoglobulin (IVIg) has had a major impact in the
successful treatment of previously untreatable or poorly controlled autoimmune neurological …

Over the past few years, we have achieved increasing success in the treatment of a number
of autoimmune-mediated disorders affecting nerves and muscles. This success is partly …

Elovaara I, Hietaharju A. Can we face the challenge of expanding use of intravenous
immunoglobulin in neurology? Acta Neurol Scand: 2010: 122: 309–315.© 2010 The Authors …

Intravenous immunoglobulin (IVIg)—a preparation of polyclonal serum IgG pooled from
thousands of blood donors—has been used for nearly three decades, and is proving to be …

Owing to its anti-inflammatory efficacy in various autoimmune disease conditions,
intravenous immunoglobulin (IVIG)—pooled IgG obtained from the plasma of several …

On the basis of controlled clinical trials, high-dose intravenous immunoglobulin (IVIg) has
emerged as a critical therapy in the management of patients with various autoimmune …

Purpose IV immunoglobulin (Ig) therapy has been widely used for the treatment of
neurologic disorders, autoimmune diseases, immunodeficiency-related diseases, blood …

Background Corticosteroids are the first-line treatment for several common autoimmune
neurological diseases. Other therapeutic approaches, including intravenous …

Intravenous immunoglobulin (IVIg) is used increasingly in the management of patients with
neurological conditions. The efficacy and safety of IVIg treatment in chronic inflammatory …

In recent years, we have witnessed an alarming worldwide shortage of intravenous
immunoglobulin, an agent that is commonly used to treat various autoimmune and systemic …